Key result
Extracorporeal ultrafiltration resulted in significantly greater weight loss at 48 hours compared to standard diuretic therapy in patients with acute decompensated heart failure (MD 1.78 kg; P<0.001).
Why the study?
Does extracorporeal venous ultrafiltration improve weight loss compared to standard diuretic treatment in patients with acute decompensated heart failure?
Meta-Analysis (n=613)
Does extracorporeal venous ultrafiltration improve weight loss compared to standard diuretic treatment in patients with acute decompensated heart failure?
Ultrafiltration provides superior short-term weight loss compared to standard diuretics in acute decompensated heart failure, but does not significantly affect serum creatinine or all-cause mortality.
Supports superior short-term decongestion in acute decompensated heart failure; confirms weight-loss benefit without renal or mortality effects.
INTRODUCTION: Although diuretics are mainly used for the treatment of acute decompensated heart failure (ADHF), inadequate responses and complications have led to the use of extracorporeal ultrafiltration (UF) as an alternative strategy for reducing volume overloads in patients with ADHF. OBJECTIVE: The aim of our study is to perform meta-analysis of the results obtained from studies on extracorporeal venous ultrafiltration and compare them with those of standard diuretic treatment for overload volume reduction in acute decompensated heart failure. METHODS: MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials databases were systematically searched using a pre‑specified criterion. Pooled estimates of outcomes after 48 h (weight change, serum creatinine level, and all-cause mortality) were computed using random effect models. Pooled weighted mean differences were calculated for weight loss and change in creatinine level, whereas a pooled risk ratio was used for the analysis of binary all-cause mortality outcome. RESULTS: A total of nine studies, involving 613 patients, met the eligibility criteria. The mean weight loss in patients who underwent UF therapy was 1.78 kg [95% Confidence Interval (CI): -2.65 to -0.91 kg; p < 0.001) more than those who received standard diuretic therapy. The post-intervention creatinine level, however, was not significantly different (mean change = -0.25 mg/dL; 95% CI: -0.56 to 0.06 mg/dL; p = 0.112). The risk of all-cause mortality persisted in patients treated with UF compared with patients treated with standard diuretics (Pooled RR = 1.00; 95% CI: 0.64-1.56; p = 0.993). CONCLUSION: Compared with standard diuretic therapy, UF treatment for overload volume reduction in individuals suffering from ADHF, resulted in significant reduction of body weight within 48 h. However, no significant decrease of serum creatinine level or reduction of all-cause mortality was observed.
No takes yet. Share an insight, caveat, or question.
Barkoudah et al. (2014) conducted a meta-analysis in Acute Decompensated Heart Failure (n=613). Extracorporeal ultrafiltration vs. Standard diuretic treatment was evaluated on Weight loss after 48 h (MD 1.78, 95% CI -2.65 to -0.91, p=<0.001). Extracorporeal ultrafiltration resulted in significantly greater weight loss at 48 hours compared to standard diuretic therapy in patients with acute decompensated heart failure (MD 1.78 kg; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: